Prostate cancer and microRNAs: New insights into apoptosis.

[1]  H. Mirzaei,et al.  Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma , 2023, Phytotherapy research : PTR.

[2]  Michael R Hamblin,et al.  Exosomal MicroRNA Profiling. , 2023, Methods in molecular biology.

[3]  Michael R Hamblin,et al.  Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression , 2022, Frontiers in Cell and Developmental Biology.

[4]  A. Shahini,et al.  Long non-coding RNAs and melanoma: From diagnosis to therapy. , 2022, Pathology, research and practice.

[5]  Michael R Hamblin,et al.  Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs , 2022, Frontiers in Cardiovascular Medicine.

[6]  A. Khajavi,et al.  The impact of conventional smoking versus electronic cigarette on the expression of VEGF, PEMPA1, and PTEN in rat prostate , 2022, Prostate international.

[7]  Michael R Hamblin,et al.  MicroRNA-383: A tumor suppressor miRNA in human cancer , 2022, Frontiers in Cell and Developmental Biology.

[8]  Michael R Hamblin,et al.  Non-coding RNAs and glioma: Focus on cancer stem cells , 2022, Molecular therapy oncolytics.

[9]  Xiaoyi Huang,et al.  MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis , 2022, Experimental & molecular medicine.

[10]  Arash Salmaninejad,et al.  Virus, Exosome, and MicroRNA: New Insights into Autophagy. , 2022, Advances in experimental medicine and biology.

[11]  X. Zeng,et al.  Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer. , 2022, Pathology, research and practice.

[12]  Michael R Hamblin,et al.  Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers , 2022, Frontiers in Oncology.

[13]  S. Freedland,et al.  Statins and prostate cancer—hype or hope? The epidemiological perspective , 2022, Prostate Cancer and Prostatic Diseases.

[14]  H. Mirzaei,et al.  Interplays between non-coding RNAs and chemokines in digestive system cancers. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Michael R Hamblin,et al.  MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy , 2022, Molecular Neurobiology.

[16]  Michael R Hamblin,et al.  Cytokines and microRNAs in SARS-CoV-2: What do we know? , 2022, Molecular Therapy - Nucleic Acids.

[17]  Wei Zhang,et al.  Long non-coding RNA MIR22HG suppresses cell proliferation and promotes apoptosis in prostate cancer cells by sponging microRNA-9-3p , 2022, Bioengineered.

[18]  Tao Sun,et al.  High miR-34a and miR-26b expressions inhibit prostate cancer cell OPCN-1 proliferation and enhances apoptosis , 2022, Tropical Journal of Pharmaceutical Research.

[19]  Michael R Hamblin,et al.  Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma. , 2022, Epigenomics.

[20]  Michael R Hamblin,et al.  Microfluidics for detection of exosomes and microRNAs in cancer: State of the art , 2022, Molecular therapy. Nucleic acids.

[21]  A. Khatami,et al.  The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease , 2022, The Brazilian Journal of Infectious Diseases.

[22]  Y. Hsieh,et al.  Targeting of Mcl-1 Expression by MiRNA-3614-5p Promotes Cell Apoptosis of Human Prostate Cancer Cells , 2022, International journal of molecular sciences.

[23]  M. Moghoofei,et al.  Human papilloma virus (HPV) and prostate cancer (PCa): The potential role of HPV gene expression and selected cellular MiRNAs in PCa development. , 2022, Microbial pathogenesis.

[24]  F. Cheng,et al.  MiR‐363‐3p promotes prostate cancer tumor progression by targeting Dickkopf 3 , 2022, Journal of clinical laboratory analysis.

[25]  Sung-Hoon Kim,et al.  BK002 Induces miR-192-5p-Mediated Apoptosis in Castration-Resistant Prostate Cancer Cells via Modulation of PI3K/CHOP , 2022, Frontiers in Oncology.

[26]  Jian Sun,et al.  Circ_0076305 facilitates prostate cancer development via sponging miR‐411‐5p and regulating PGK1 , 2022, Andrologia.

[27]  Wenhui Zhao,et al.  The lncRNA NEAT1/miRNA-766-5p/E2F3 Regulatory Axis Promotes Prostate Cancer Progression , 2022, Journal of oncology.

[28]  Michael R Hamblin,et al.  MicroRNA let-7 and viral infections: focus on mechanisms of action , 2022, Cellular & molecular biology letters.

[29]  M. Aschner,et al.  Quercetin and Glioma: Which signaling pathways are involved? , 2022, Current molecular pharmacology.

[30]  Michael R Hamblin,et al.  Non-coding RNAs and glioblastoma: Insight into their roles in metastasis , 2021, Molecular therapy oncolytics.

[31]  Xiao-hou Wu,et al.  Long non-coding RNA lncHUPC1 induced by FOXA1 promotes tumor progression by inhibiting apoptosis via miR-133b/SDCCAG3 in prostate cancer. , 2022, American journal of cancer research.

[32]  S. Niture,et al.  MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. , 2022, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[33]  Michael R Hamblin,et al.  Non-Coding RNAs and Brain Tumors: Insights Into Their Roles in Apoptosis , 2022, Frontiers in Cell and Developmental Biology.

[34]  Y. Gong,et al.  MiR-145-5p Inhibits the Invasion of Prostate Cancer and Induces Apoptosis by Inhibiting WIP1 , 2021, Journal of oncology.

[35]  M. Aschner,et al.  miRNA-148b and its role in various cancers. , 2021, Epigenomics.

[36]  Ebru Temiz,et al.  miR-19a and miR-421 target PCA3 long non-coding RNA and restore PRUNE2 tumor suppressor activity in prostate cancer , 2021, Molecular Biology Reports.

[37]  Xisheng Wang,et al.  Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA‐198 decoy , 2021, Andrologia.

[38]  M. Akbari,et al.  Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study. , 2021, Tissue & cell.

[39]  A. Basiri,et al.  The Role and Clinical Potentials of Circular RNAs in Prostate Cancer , 2021, Frontiers in Oncology.

[40]  A. Bagherian,et al.  Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib. , 2021, Food & function.

[41]  Michael R Hamblin,et al.  MicroRNA-155 and antiviral immune responses. , 2021, International immunopharmacology.

[42]  N. Sharma,et al.  miR-221 regulates proliferation, invasion, apoptosis and progression of prostate cancer cells by modulating E-cadherin/Wnt/β catenin axis , 2021 .

[43]  Michael R Hamblin,et al.  Roles of Non-coding RNAs and Angiogenesis in Glioblastoma , 2021, Frontiers in Cell and Developmental Biology.

[44]  Michael R Hamblin,et al.  Dysregulated expression of miRNAs in immune thrombocytopenia. , 2021, Epigenomics.

[45]  M. Moghoofei,et al.  Evaluation of the expression pattern of 4 microRNAs and their correlation with cellular/viral factors in PBMCs of Long Term non-progressors and HIV infected naïve Individuals. , 2021, Current HIV Research.

[46]  D. Spratt,et al.  Racial disparities in prostate cancer among black men: epidemiology and outcomes , 2021, Prostate Cancer and Prostatic Diseases.

[47]  Jianquan Hou,et al.  miR-499a inhibits the proliferation and apoptosis of prostate cancer via targeting UBE2V2 , 2021, World Journal of Surgical Oncology.

[48]  B. Yousefi,et al.  MiR‐622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer , 2021, Andrologia.

[49]  Zhangren Yan,et al.  miRNA-877-5p inhibits malignant progression of prostate cancer by directly targeting SSFA2 , 2021, European journal of histochemistry : EJH.

[50]  M. Aschner,et al.  Aquaporin 4 and brain-related disorders: Insights into its apoptosis roles , 2021, EXCLI journal.

[51]  Gonghui Li,et al.  Role of noncoding RNA in drug resistance of prostate cancer , 2021, Cell Death & Disease.

[52]  M. Aschner,et al.  New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[53]  Xiangxuan Zhao,et al.  Targeting Bcl-2 for cancer therapy. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[54]  Michael R Hamblin,et al.  Plant-based vaccines and cancer therapy: Where are we now and where are we going? , 2021, Pharmacological research.

[55]  Jing Zhang,et al.  Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis , 2021, Drug design, development and therapy.

[56]  Michael R Hamblin,et al.  Angiogenesis-related non-coding RNAs and gastrointestinal cancer , 2021, Molecular therapy oncolytics.

[57]  Michael R Hamblin,et al.  Cell death pathways and viruses: Role of microRNAs , 2021, Molecular therapy. Nucleic acids.

[58]  Daniel Lee.  miR-769-5p is associated with prostate cancer recurrence and modulates proliferation and apoptosis of cancer cells , 2021, Experimental and therapeutic medicine.

[59]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[60]  S. Kalantar,et al.  Co-delivery of miRNA-15a and miRNA-16–1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells , 2021, Biotechnology Letters.

[61]  P. Qi,et al.  miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin , 2021, Cell death discovery.

[62]  Nima Hemmat,et al.  The role of Th17 cells in viral infections. , 2021, International immunopharmacology.

[63]  Dong Chen,et al.  Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress malignant characteristics and promote apoptosis in prostate cancer cells , 2021, Bioengineered.

[64]  Yang Lifen,et al.  miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway , 2021, The Libyan journal of medicine.

[65]  Zhenhua Gu,et al.  Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways , 2021, Bioengineered.

[66]  M. He,et al.  MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2 , 2021, Technology in cancer research & treatment.

[67]  Michael R Hamblin,et al.  Effects of therapeutic probiotics on modulation of microRNAs , 2020, Cell communication and signaling : CCS.

[68]  Y. Niu,et al.  Circ_0001686 Promotes Prostate Cancer Progression by Up-Regulating SMAD3/TGFBR2 via miR-411-5p , 2020, The world journal of men's health.

[69]  M. Aschner,et al.  Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players , 2021, Frontiers in Cardiovascular Medicine.

[70]  M. Moghoofei,et al.  The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. , 2020, Microbial pathogenesis.

[71]  Michael R Hamblin,et al.  Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. , 2020, Critical reviews in oncology/hematology.

[72]  Qing-zuo Liu,et al.  LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis , 2020, Cancer biology & therapy.

[73]  Zhirong Zhu,et al.  MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2 , 2020, Experimental and therapeutic medicine.

[74]  Yang Cheng,et al.  TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR-155 , 2020, Molecular medicine reports.

[75]  Michael R Hamblin,et al.  Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect , 2020, Molecular therapy oncolytics.

[76]  H. Mirzaei,et al.  Circular RNAs: New players in thyroid cancer. , 2020, Pathology, research and practice.

[77]  M. Ashrafizadeh,et al.  Sensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers. , 2020, Pharmacological research.

[78]  Michael R Hamblin,et al.  Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages , 2020, Cell communication and signaling : CCS.

[79]  M. Darvish,et al.  The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis. , 2020, International immunopharmacology.

[80]  H. Mirzaei,et al.  Circular RNA as a potential diagnostic and/or therapeutic target for endometriosis. , 2020, Biomarkers in medicine.

[81]  Michael R Hamblin,et al.  Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis. , 2020, Pathology, research and practice.

[82]  H. Mirzaei,et al.  Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. , 2020, Pharmacological research.

[83]  Biao Zhang,et al.  LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1 , 2020, Cancer Cell International.

[84]  Michael R Hamblin,et al.  Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis , 2020, Cell Communication and Signaling.

[85]  Qin Li,et al.  miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis , 2020, OncoTargets and therapy.

[86]  Zhiqiang Duan,et al.  miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway , 2020, Cancer management and research.

[87]  Michael R Hamblin,et al.  Circular RNAs: New Epigenetic Signatures in Viral Infections , 2020, Frontiers in Microbiology.

[88]  Amin Jalili,et al.  Autophagy-related MicroRNAs in chronic lung diseases and lung cancer. , 2020, Critical reviews in oncology/hematology.

[89]  Michael R Hamblin,et al.  Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways , 2020, Journal of Molecular Neuroscience.

[90]  Hong Zhang,et al.  MicroRNA‑16‑5p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells. , 2020, Oncology reports.

[91]  M. Moghoofei,et al.  The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. , 2020, Microbial pathogenesis.

[92]  Michael R Hamblin,et al.  TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus , 2020, Cell Communication and Signaling.

[93]  M. Mansournia,et al.  Circular RNAs: new genetic tools in melanoma. , 2020, Biomarkers in medicine.

[94]  B. Baradaran,et al.  MicroRNA-143 inhibits proliferation and migration of prostate cancer cells , 2020, Archives of physiology and biochemistry.

[95]  Michael R Hamblin,et al.  Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis , 2020, Molecular therapy. Nucleic acids.

[96]  D. Del Bufalo,et al.  Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer , 2020, Cells.

[97]  H. Zeng,et al.  MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8 , 2020, Translational cancer research.

[98]  J. Xing,et al.  miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 , 2020, Cancer management and research.

[99]  Z. Razavi,et al.  Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy , 2020, IUBMB life.

[100]  W. El-Deiry,et al.  Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.

[101]  Hao Wang,et al.  MicroRNA-337-3p suppresses cell viability, apoptosis, and autophagy by modulating PPARγ expression in androgen-dependent human prostate cancer , 2020 .

[102]  Jiaqian Pan,et al.  lncRNA ZFAS1 Is Involved in the Proliferation, Invasion and Metastasis of Prostate Cancer Cells Through Competitively Binding to miR-135a-5p , 2020, Cancer management and research.

[103]  K. Abbaszadeh-Goudarzi,et al.  Circular RNA and Diabetes: Epigenetic Regulator with Diagnostic role. , 2020, Current molecular medicine.

[104]  Yan Cao,et al.  LncRNA NEAT1 facilitates pancreatic cancer growth and metastasis through stabilizing ELF3 mRNA. , 2020, American journal of cancer research.

[105]  Peng Wang,et al.  SP1‐mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR‐377 to facilitate prostate cancer progression through regulation of ZIC5 , 2020, Journal of cellular physiology.

[106]  Yingbo Ma,et al.  LncRNA NEAT1 promotes autophagy via regulating miR‐204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma , 2020, Journal of cellular physiology.

[107]  Y. Ghasemi,et al.  The role of microRNAs in Lung Cancer: Implications for diagnosis and therapy. , 2020, Current molecular medicine.

[108]  L. Hua,et al.  MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression , 2019, Journal of cellular and molecular medicine.

[109]  Michael R Hamblin,et al.  Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. , 2019, Critical reviews in oncology/hematology.

[110]  Lei Wang,et al.  Long noncoding RNA MIR22HG is down-regulated in prostate cancer. , 2019, Mathematical biosciences and engineering : MBE.

[111]  Sheng-jie Guo,et al.  Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2 , 2019, Journal of experimental & clinical cancer research : CR.

[112]  H. Mirzaei,et al.  Role of resveratrol in modulating microRNAs in human diseases: From cancer to inflammatory disorder. , 2019, Current medicinal chemistry.

[113]  Gonghui Li,et al.  lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143 , 2019, Molecular therapy. Nucleic acids.

[114]  B. Schilling,et al.  miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1 , 2019, BioMed research international.

[115]  Shaoxiong Zhao,et al.  miR‐4286 promotes prostate cancer progression by targeting the expression of SALL1 , 2019, The journal of gene medicine.

[116]  R. Ray,et al.  miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression , 2019, Cells.

[117]  Michael R Hamblin,et al.  miRNAs derived from cancer-associated fibroblasts in colorectal cancer. , 2019, Epigenomics.

[118]  Ji-Ping Wang,et al.  MicroRNA‐498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN , 2019, The Kaohsiung journal of medical sciences.

[119]  Michael R Hamblin,et al.  Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review , 2019, International journal of cancer.

[120]  A. Avan,et al.  Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. , 2019, Pathology, research and practice.

[121]  Y. Ghasemi,et al.  Electrochemical-based biosensors for microRNA detection: Nanotechnology comes into view. , 2019, Analytical biochemistry.

[122]  N. Sharifi,et al.  Anti-cancer effects of cinnamon: Insights into its apoptosis effects. , 2019, European journal of medicinal chemistry.

[123]  Y. Ghasemi,et al.  Circular RNAs in cancer: new insights into functions and implications in ovarian cancer , 2019, Journal of Ovarian Research.

[124]  Rajesh Singh,et al.  Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway , 2019, Cancers.

[125]  F. Boccardo,et al.  Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer , 2019, Cancers.

[126]  P. Tassone,et al.  Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma , 2019, Leukemia.

[127]  Ying Shi,et al.  Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3 , 2019, Molecular therapy. Nucleic acids.

[128]  Yin Liu,et al.  miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway , 2019, Journal of Biosciences.

[129]  Jiajie Fang,et al.  Nonconserved miR‐608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 pathways by targeting the 3′‐UTRs of RAC2/BCL2L1 and the coding region of PAK4 , 2019, Cancer medicine.

[130]  Bing Zhong,et al.  miR‑589‑5p is downregulated in prostate cancer and regulates tumor cell viability and metastasis by targeting CCL‑5. , 2019, Molecular medicine reports.

[131]  P. Duijf,et al.  MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. , 2019, Free radical biology & medicine.

[132]  S. Patra,et al.  miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability. , 2019, Gene.

[133]  Guoan Chen,et al.  LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling , 2019, Aging.

[134]  R. Dahiya,et al.  MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells , 2019, Scientific Reports.

[135]  S. Niture,et al.  Abstract 3561: MicroRNA-214 inhibits prostate cancer cell proliferation, migration, invasion and increases drug sensitivity by targeting PTK6 , 2019, Molecular and Cellular Biology / Genetics.

[136]  Yi Zhou,et al.  LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4 , 2019, Cell Death & Disease.

[137]  Chen Fang,et al.  MicroRNA-145 inhibits proliferation and induces apoptosis in human prostate carcinoma by upregulating long non-coding RNA GAS5 , 2019, Oncology letters.

[138]  Yuqi Wu,et al.  MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells. , 2019, Molecular medicine reports.

[139]  Jiangui Lin,et al.  Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19. , 2019, Gene.

[140]  Yi Lu,et al.  Effect of miR-200c on proliferation, invasion and apoptosis of prostate cancer LNCaP cells , 2019, Oncology letters.

[141]  Shenglin Huang,et al.  LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR‐10a‐5p/NCOR2 axis in hepatocellular carcinoma cells , 2019, Cancer science.

[142]  Can Wang,et al.  MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway , 2019, Cancer medicine.

[143]  Sang Kook Lee,et al.  Circular RNAs in Cancer , 2019, Molecular therapy. Nucleic acids.

[144]  G. Azizi,et al.  The role of microRNAs in prostate cancer migration, invasion, and metastasis , 2018, Journal of cellular physiology.

[145]  Lihua Zhang,et al.  MicroRNA-135a induces prostate cancer cell apoptosis via inhibition of STAT6. , 2018, Oncology letters.

[146]  P. Codoñer-Franch,et al.  Molecular aspects of pancreatic β‐cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA , 2018, Journal of cellular physiology.

[147]  H. Mirzaei,et al.  Role of microRNAs in chronic lymphocytic leukemia pathogenesis. , 2019, Current medicinal chemistry.

[148]  H. Mirzaei,et al.  Long Non-Coding RNAs: Epigenetic Regulators in Cancer. , 2019, Current pharmaceutical design.

[149]  Y. Wen,et al.  miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5. , 2019, Cancer biomarkers : section A of Disease markers.

[150]  Ren-Zong Chen,et al.  miR-448 inhibits proliferation and induces apoptosis in prostate cancer cells by modulating cyclin-dependent kinase 19 expression , 2019 .

[151]  Yifan Liu,et al.  MicroRNA-140 inhibits proliferation and promotes apoptosis and cell cycle arrest of prostate cancer via degrading SOX4. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[152]  Reza Salarinia,et al.  MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer. , 2019, Critical reviews in eukaryotic gene expression.

[153]  H. Qin,et al.  miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells. , 2018, American journal of cancer research.

[154]  B. You,et al.  MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55. , 2018, European review for medical and pharmacological sciences.

[155]  W. Nahas,et al.  MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line , 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[156]  T. Zhu,et al.  Circular RNA Expression Profiling Identifies Prostate Cancer- Specific circRNAs in Prostate Cancer , 2018, Cellular Physiology and Biochemistry.

[157]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[158]  X. Li,et al.  KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer , 2018, Cell Communication and Signaling.

[159]  S. Khan,et al.  miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy , 2018, Cancers.

[160]  Xunbo Jin,et al.  MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells. , 2018, Oncology research.

[161]  Weijie Cheng,et al.  MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55. , 2018, American journal of translational research.

[162]  Ghazal Haddad,et al.  miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines , 2018, Asian Pacific journal of cancer prevention : APJCP.

[163]  Ronggang Li,et al.  Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling , 2018, Journal of experimental & clinical cancer research : CR.

[164]  M. Wiesehöfer,et al.  The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells , 2018, PloS one.

[165]  F. Fu,et al.  Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer. , 2018, Gene.

[166]  Fei Yang,et al.  miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA. , 2018, Experimental and therapeutic medicine.

[167]  S. Mousavi,et al.  MicroRNAs and exosomes in depression: Potential diagnostic biomarkers , 2018, Journal of cellular biochemistry.

[168]  H. Mirzaei,et al.  Circulating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker , 2018, Journal of cancer research and therapeutics.

[169]  G. Dong,et al.  Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer. , 2018, International journal of molecular medicine.

[170]  K. Horie-Inoue,et al.  Prostate cancer-associated lncRNAs. , 2018, Cancer letters.

[171]  H. Mirzaei,et al.  MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers , 2018, Journal of cellular physiology.

[172]  N. Chen,et al.  MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components , 2018, The Prostate.

[173]  Y. Shao,et al.  MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[174]  Amareshwar T. K. Singh,et al.  Apoptosis: A Target for Anticancer Therapy , 2018, International journal of molecular sciences.

[175]  H. Mirzaei,et al.  MiR‐21: A key player in glioblastoma pathogenesis , 2018, Journal of cellular biochemistry.

[176]  A. Avan,et al.  GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma , 2018, Journal of cellular physiology.

[177]  Hamed Mirzaei,et al.  MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer , 2018, Journal of cellular physiology.

[178]  J. Stenvang,et al.  State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia , 2018, Journal of cellular physiology.

[179]  S. Kouhpayeh,et al.  MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy , 2018, Journal of cellular physiology.

[180]  P. Codoñer-Franch,et al.  Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome , 2018, Journal of cellular biochemistry.

[181]  Zhongmin Zhang,et al.  MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-κB signaling pathway activation , 2018, Oncology letters.

[182]  Mohsen Poursadeghiyan,et al.  Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes , 2018, Journal of cellular biochemistry.

[183]  Junhua Zheng,et al.  microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[184]  Dan Wang,et al.  MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression , 2017, Oncotarget.

[185]  D. Green,et al.  MOMP, cell suicide as a BCL-2 family business , 2017, Cell Death and Differentiation.

[186]  Bahman Rashidi,et al.  MicroRNA: A novel target of curcumin in cancer therapy , 2017, Journal of cellular physiology.

[187]  Qiang Zhou,et al.  Enhanced expression of miR-375 increases chemotherapy sensitivity of prostate cancer to cisplatin , 2018 .

[188]  Xiaobin Zhang,et al.  miRNA-627 inhibits cell proliferation and cell migration, promotes cell apoptosis in prostate cancer cells through upregulating MAP3K1, PTPRK and SRA1. , 2018, International journal of clinical and experimental pathology.

[189]  A. Panda.  Circular RNAs Act as miRNA Sponges. , 2018, Advances in experimental medicine and biology.

[190]  W. Xiong,et al.  Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway. , 2018, The international journal of biochemistry & cell biology.

[191]  Lei Chen,et al.  MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1 , 2018, World Journal of Urology.

[192]  Yanling Zhao,et al.  Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy , 2017, Oncotarget.

[193]  H. Mirzaei.  Stroke in Women: Risk Factors and Clinical Biomarkers , 2017, Journal of cellular biochemistry.

[194]  Shuxia Wang,et al.  The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer. , 2017, International journal of biological macromolecules.

[195]  Zhen Liang,et al.  MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway , 2017, Oncotarget.

[196]  Y. Hsieh,et al.  Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells. , 2017, Biochimica et biophysica acta. Molecular cell research.

[197]  T. Hwang,et al.  Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. , 2017, Asian journal of surgery.

[198]  W. Zhong,et al.  miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein , 2017, Molecular medicine reports.

[199]  Hui Wang,et al.  Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling. , 2017, Urology.

[200]  J. Arbiser,et al.  Targeting the duality of cancer , 2017, npj Precision Oncology.

[201]  C. Collins,et al.  miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer , 2017, Scientific Reports.

[202]  Weifeng Yu,et al.  miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway. , 2017, Oncology reports.

[203]  O. Ogunwobi,et al.  A novel microRNA-1207-3p/FNDC1/FN1/AR regulatory pathway in prostate cancer. , 2017, RNA & disease.

[204]  Yu-jie Wang,et al.  MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression. , 2017, Biochemical and biophysical research communications.

[205]  Zhiwei Ma,et al.  miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[206]  Yeqing Huang,et al.  MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling , 2017, Oncotarget.

[207]  G. Stein,et al.  MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2 , 2017, Cell Death and Disease.

[208]  Weidong Zhou,et al.  Suppression of miR-4735-3p in androgen receptor-expressing prostate cancer cells increases cell death during chemotherapy. , 2017, American journal of translational research.

[209]  Jian Wang,et al.  microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1). , 2017, American journal of translational research.

[210]  A. Avan,et al.  Cytokines and MicroRNA in Coronary Artery Disease. , 2017, Advances in clinical chemistry.

[211]  S. Mousavi,et al.  Glioblastoma: exosome and microRNA as novel diagnosis biomarkers , 2016, Cancer Gene Therapy.

[212]  Yongxing Wang,et al.  Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line. , 2016, Oncology reports.

[213]  Jianguo Huang,et al.  Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2. , 2016, Oncology letters.

[214]  R. Salehi,et al.  Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies. , 2016, Current cancer drug targets.

[215]  A. Avan,et al.  Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. , 2016, Current medicinal chemistry.

[216]  M. Jaafari,et al.  Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma , 2016, Cancer Gene Therapy.

[217]  Shu Yang,et al.  Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression. , 2016, The international journal of biochemistry & cell biology.

[218]  A. Sahebkar,et al.  Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia , 2016, Cancer Gene Therapy.

[219]  Yeqing Huang,et al.  miRNA-30a functions as a tumor suppressor by downregulating cyclin E2 expression in castration-resistant prostate cancer. , 2016, Molecular medicine reports.

[220]  Mohammad Jafari,et al.  Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. , 2016, Current pharmaceutical design.

[221]  K. D. Sørensen,et al.  The Potential of MicroRNAs as Prostate Cancer Biomarkers. , 2016, European urology.

[222]  A. Hamid,et al.  The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review. , 2016, Acta medica Indonesiana.

[223]  Yongning Sun,et al.  Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301 , 2016, OncoTargets and therapy.

[224]  Yue Wang,et al.  Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway. , 2016, Biochemical and biophysical research communications.

[225]  M. Harada,et al.  Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells , 2016, International journal of oncology.

[226]  Lina Chen,et al.  MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer. , 2016, Molecular medicine reports.

[227]  Yuxin Tang,et al.  MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway. , 2016, Oncology reports.

[228]  A. Avan,et al.  The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. , 2015, Current pharmaceutical design.

[229]  A. Avan,et al.  MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. , 2016, European journal of cancer.

[230]  Hong Zhang,et al.  miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells , 2016, Tumor Biology.

[231]  Zhe Zhang,et al.  MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo , 2016, Tumor Biology.

[232]  C. Tepper,et al.  miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. , 2015, Cancer research.

[233]  M. G. Paulraj,et al.  MicroRNA in prostate cancer. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[234]  Yeqing Huang,et al.  Hsa‐miR‐146a‐5p modulates androgen‐independent prostate cancer cells apoptosis by targeting ROCK1 , 2015, The Prostate.

[235]  Peng-ju Zhang,et al.  Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. , 2015, Gene.

[236]  T. Deguchi,et al.  miR‐130a activates apoptotic signaling through activation of caspase‐8 in taxane‐resistant prostate cancer cells , 2015, The Prostate.

[237]  C. Perez-stable,et al.  Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage , 2015, Oncoscience.

[238]  Jianxin Diao,et al.  Bax-PGAM5L-Drp1 complex is required for intrinsic apoptosis execution , 2015, Oncotarget.

[239]  Jing Yang,et al.  RLIP76-dependent suppression of PI3K/AKT/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer. , 2015, Biochemical and biophysical research communications.

[240]  Bo Jiang,et al.  Role of MicroRNAs in Prostate Cancer Pathogenesis. , 2015, Clinical genitourinary cancer.

[241]  Zlatko Trajanoski,et al.  miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer. , 2015, Molecular endocrinology.

[242]  Yiduo Wang,et al.  MicroRNA‐19a regulates proliferation and apoptosis of castration‐resistant prostate cancer cells by targeting BTG1 , 2015, FEBS letters.

[243]  C. Creighton,et al.  Overexpression of miR-145–5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression , 2015, Cancer investigation.

[244]  Xuechao Wan,et al.  MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation. , 2015, International journal of clinical and experimental medicine.

[245]  S. Tait,et al.  Mitochondrial apoptosis: killing cancer using the enemy within , 2015, British Journal of Cancer.

[246]  Xinjun Zhang,et al.  microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression. , 2015, Biochemical and biophysical research communications.

[247]  Jianxiang Wang,et al.  MicroRNA regulation and therapeutic targeting of survivin in cancer. , 2015, American journal of cancer research.

[248]  Eugenia G. Giannopoulou,et al.  The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.

[249]  G. Jeschke,et al.  Structural model of active Bax at the membrane. , 2014, Molecular cell.

[250]  Sung-Hoon Kim,et al.  Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis , 2014, Oncotarget.

[251]  G. Tonon,et al.  RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS , 2014, Nature Medicine.

[252]  R. Dahiya,et al.  Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer , 2014, Molecular Cancer Therapeutics.

[253]  M. Hsiao,et al.  MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo , 2014, Oncogenesis.

[254]  Jingqiang Wang,et al.  Identification of miR-133b and RB1CC1 as Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer , 2014, Clinical Cancer Research.

[255]  Lei Zhang,et al.  MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). , 2014, Biochemical and biophysical research communications.

[256]  K. Riabowol,et al.  Survivin as a Preferential Target for Cancer Therapy , 2014, International journal of molecular sciences.

[257]  L. Feng,et al.  Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells , 2014, Leukemia.

[258]  Y. Harazono,et al.  Why anti-Bcl-2 clinical trials fail: a solution , 2014, Cancer and Metastasis Reviews.

[259]  Peter E. Czabotar,et al.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.

[260]  Qun Liu,et al.  MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells , 2013, BMC Complementary and Alternative Medicine.

[261]  C. Stephan,et al.  The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1 , 2013, PloS one.

[262]  B. V. Chakravarthi,et al.  Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani , 2013, Cancer Cell International.

[263]  Anna L. Walsh,et al.  Noncoding RNAs in Prostate Cancer: The Long and the Short of It , 2013, Clinical Cancer Research.

[264]  M. Mourtada-Maarabouni,et al.  Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. , 2013, Biochimica et biophysica acta.

[265]  C. Tepper,et al.  Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells , 2013, Oncogene.

[266]  C. Qin,et al.  miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. , 2013, Asian journal of andrology.

[267]  Jayoung Kim,et al.  MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells , 2013, PloS one.

[268]  Dong Xu,et al.  MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. , 2013, Molecular medicine reports.

[269]  Markus Vogt,et al.  MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. , 2013, International journal of oncology.

[270]  Li Wang,et al.  MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[271]  Randy S. Schrecengost,et al.  Molecular pathogenesis and progression of prostate cancer. , 2013, Seminars in oncology.

[272]  D. Altieri.  Targeting survivin in cancer. , 2013, Cancer letters.

[273]  H. Kung,et al.  Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer , 2013, PloS one.

[274]  S. Majid,et al.  The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression , 2013, Journal of the National Cancer Institute.

[275]  G. Wahl,et al.  MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.

[276]  Kang Han,et al.  miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. , 2012, Oncology reports.

[277]  Michael V. Fiandalo,et al.  Caspase control: protagonists of cancer cell apoptosis. , 2012, Experimental oncology.

[278]  N. Saini,et al.  Downregulation of BCL2 by miRNAs augments drug-induced apoptosis – a combined computational and experimental approach , 2012, Journal of Cell Science.

[279]  A. Schäffer,et al.  The phenotype of human STK4 deficiency. , 2011, Blood.

[280]  Rebecca SY Wong,et al.  Apoptosis in cancer: from pathogenesis to treatment , 2011, Journal of experimental & clinical cancer research : CR.

[281]  H. Lähdesmäki,et al.  The miR‐15a‐miR‐16‐1 locus is homozygously deleted in a subset of prostate cancers , 2011, Genes, chromosomes & cancer.

[282]  R. Dahiya,et al.  The functional significance of microRNA-145 in prostate cancer , 2010, British Journal of Cancer.

[283]  H. Lilja,et al.  miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions , 2010, International journal of cancer.

[284]  Rajvir Dahiya,et al.  MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer , 2010, Cancer.

[285]  Qunshu Zhang,et al.  Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells , 2010, Cell Death and Disease.

[286]  Jianyuan Luo,et al.  SIRT1 and p53, effect on cancer, senescence and beyond. , 2010, Biochimica et biophysica acta.

[287]  Liang Xu,et al.  Chemosensitization of prostate cancer by modulating Bcl-2 family proteins. , 2010, Current drug targets.

[288]  Huiqing Yuan,et al.  MicroRNAs and prostate cancer. , 2010, Acta biochimica et biophysica Sinica.

[289]  Subbaya Subramanian,et al.  MicroRNAs as gatekeepers of apoptosis , 2010, Journal of cellular physiology.

[290]  C. Croce,et al.  miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.

[291]  R. M. Simpson,et al.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression , 2010, Proceedings of the National Academy of Sciences.

[292]  Osamu Takeuchi,et al.  Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. , 2009, Molecular cell.

[293]  Jeannie T. Lee,et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.

[294]  M. Hsiao,et al.  MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation , 2009, Oncogene.

[295]  P. Sun,et al.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. , 2009, Biochemical and biophysical research communications.

[296]  G. Gores,et al.  Life and death by death receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[297]  B. Lin,et al.  Effect of miR-296 on the Apoptosis of Androgen-independent Prostate Cancer Cells , 2009 .

[298]  W. Gu,et al.  How does SIRT1 affect metabolism, senescence and cancer? , 2009, Nature Reviews Cancer.

[299]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[300]  Yasunori Fujita,et al.  Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. , 2008, Biochemical and biophysical research communications.

[301]  D. Andrews,et al.  Bid: a Bax-like BH3 protein , 2008, Oncogene.

[302]  Mauro Biffoni,et al.  The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.

[303]  John Calvin Reed,et al.  Bcl-2 family proteins and cancer , 2008, Oncogene.

[304]  D. Bumcrot,et al.  MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer , 2008, Cancer biology & therapy.

[305]  T. Fan,et al.  Inhibitor of apoptosis proteins and apoptosis. , 2008, Acta biochimica et biophysica Sinica.

[306]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[307]  W. Fairbrother,et al.  The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer , 2007, Clinical Cancer Research.

[308]  W. Jetz,et al.  Global patterns and determinants of vascular plant diversity , 2007, Proceedings of the National Academy of Sciences.

[309]  M. Jovanović,et al.  miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.

[310]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[311]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[312]  N. Kyprianou,et al.  Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance , 2006, Journal of cellular biochemistry.

[313]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[314]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[315]  A. Safa,et al.  Taxol Induces Caspase-10-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[316]  Mark F McCarty,et al.  Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy , 2004, Integrative cancer therapies.

[317]  Peizhang Xu,et al.  MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.

[318]  Gangduo Wang,et al.  Apoptosis in prostate cancer: progressive and therapeutic implications (Review). , 2004, International journal of molecular medicine.

[319]  D. Stern.  More than a Marker… Phosphorylated Akt in Prostate Carcinoma , 2004, Clinical Cancer Research.

[320]  D. Hallahan,et al.  XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer , 2004, Oncogene.

[321]  K. Do,et al.  Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer , 2004, Clinical Cancer Research.

[322]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[323]  H. Klocker,et al.  Long‐term androgen‐ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells , 2004, The Prostate.

[324]  Min Chen,et al.  Initiator caspases in apoptosis signaling pathways , 2002, Apoptosis.

[325]  Inmaculada Hernández,et al.  Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. , 2003, Molecular cancer research : MCR.

[326]  P. Nelson,et al.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.

[327]  Wenhua Gao,et al.  Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. , 2003, Genes & development.

[328]  T. McDonnell,et al.  Molecular markers of outcome after radiotherapy in patients with prostate carcinoma , 2003, Cancer.

[329]  Joanna K. Sax,et al.  BID regulation by p53 contributes to chemosensitivity , 2002, Nature Cell Biology.

[330]  Mason R. Mackey,et al.  Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.

[331]  Y. Whang,et al.  PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway , 2002, Oncogene.

[332]  Wafik S El-Deiry,et al.  Defining characteristics of Types I and II apoptotic cells in response to TRAIL. , 2002, Neoplasia.

[333]  H. Chun,et al.  Caspase-10 is an initiator caspase in death receptor signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[334]  T. Ohyama,et al.  MST, a Physiological Caspase Substrate, Highly Sensitizes Apoptosis Both Upstream and Downstream of Caspase Activation* , 2001, The Journal of Biological Chemistry.

[335]  Miguel Srougi,et al.  Abnormal Expression of MDM2 in Prostate Carcinoma , 2001, Modern Pathology.

[336]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[337]  G. Rodan,et al.  Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis , 1999, The Journal of Biological Chemistry.

[338]  P. Biberfeld,et al.  The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors , 1999, The Journal of experimental medicine.

[339]  M. Ultsch,et al.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. , 1999, Molecular cell.

[340]  W. Yung,et al.  Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. , 1999, Cancer research.

[341]  A. Borkowski,et al.  bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. , 1998, Urology.

[342]  L. Hood,et al.  Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. , 1997, Immunity.

[343]  J. Tschopp,et al.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.

[344]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[345]  Manuel C. Peitsch,et al.  Characterization of Fas (Apo-1, CD95)-Fas Ligand Interaction* , 1997, The Journal of Biological Chemistry.

[346]  R. Weichselbaum,et al.  Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[347]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[348]  D. McConkey,et al.  Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. , 1996, Cancer research.

[349]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain , 1996, Nature.

[350]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[351]  John Calvin Reed,et al.  Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2 (*) , 1996, The Journal of Biological Chemistry.

[352]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[353]  W. W. Nichols,et al.  p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. , 1993, Journal of the National Cancer Institute.

[354]  D. Chopin,et al.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. , 1993, The American journal of pathology.

[355]  M. Campbell,et al.  Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.

[356]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.